Clinical Trial

A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings

Study acronym: CervImage
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the design and engineering of a new minimally invasive medical imaging device (CervImage™). Investigators are trying to find out if CervImage™ is reliable and easy to use to obtain clinical 3D photographs and to record 3D measurements in human cervixes. Investigators then plan to use these images to determine if CervImage™ design and engineering improvements need to be made.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-01-31; most recent amendment 2026-03-16.
Status change: Recruiting → Active, Not Recruiting 2025-05-22
Trial Details
NCT Number NCT06810427
Lead Sponsor Carilion Clinic
Collaborators: National Cancer Institute (NCI), Pensievision, Inc
Conditions Cervical Intraepithelial Neoplasia
Enrollment 18 participants
Start Date 2025-01-16
Primary Completion 2025-05-16 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-18